Page 73 - Read Online
P. 73

Page 250               Thomas et al. J Transl Genet Genom 2024;8:249-77  https://dx.doi.org/10.20517/jtgg.2024.15

               INTRODUCTION
               The prostate, an exocrine gland located beneath the urinary bladder and surrounding the urethra, is
               essential for male reproductive function. During embryonic development, epithelial buds from the
               urogenital  sinus  interact  with  mesenchyme,  driving  prostate  differentiation  and  secretory  duct
                        [1-3]
               formation . Cancer of the prostate gland, the most diagnosed cancer in men and the second-leading cause
                                                                            [4-6]
               of male cancer deaths in the United States, typically progresses slowly . Prostate cancer incidence and
               mortality rates are closely linked to aging. Additionally, in the United States, African American men have a
                                                                                                       [4,7]
               higher incidence rate of developing aggressive prostate cancer compared to their Caucasian counterparts .
               While localized disease responds well to surgery or radiation, 20% to 50% of patients experience biochemical
                                                                          [7]
               recurrence within a decade, leading to advanced or metastatic cancer . The prostate stroma plays a critical
               role in promoting the progression of advanced prostate cancer .
                                                                   [8]

               In adult differentiated biology, the physical and biochemical interactions between the epithelial cells
               together with cellular and non-cellular components of the stroma regulate normal prostate function and
               homeostasis . The prostate stroma is composed of smooth muscle cells, tissue-resident mesenchymal cells,
                         [9]
               extracellular matrix (ECM) proteins, nerves, blood vessels, and a spectrum of immune cells [Figure 1] [9-11] .
               During development, androgen secreted by the testis is the chief regulator of prostate gland growth, and the
               hormonal action is mediated through the androgen receptor (AR) . However, tissue recombination
                                                                           [12]
               experiments have revealed that the androgenic effects on prostate gland growth and development are not
               solely dependent on epithelial AR but require paracrine signaling induced by the AR-positive prostate
               mesenchyme [13,14] . Disruptions in the functional coupling between the stromal and epithelial interactions in
               the adult prostate are associated with glandular dysfunction typified in aging and disease, although specific
               mechanisms remain undefined. Considerable evidence suggests these biological disruptions are associated
               with a transition into a repair-centric, emergency, or emergent tissue systems biology state to affect rapid
               repair until the biological priority resets to functional, differentiated biology . However, an unresolved/
                                                                                 [15]
               chronic repair state of the stroma, defined as reactive stroma, has been correlated with promoting the
               evolution of pathological processes including benign prostate hyperplasia (BPH) and prostate cancer [15-18]
               [Figure 1].

               Currently, there is very limited information available on both tissue-resident immune cells in healthy adult
               prostate and the modulations that occur in the immune landscape in a disease state like cancer. Often co-
               evolving with cancer, the reactive stroma is an environment enriched with growth factors and characterized
               by increased angiogenesis, an increased inflammatory response, and an extensively remodeled ECM
               resulting in a desmoplastic reaction [11,19] . The reactive stroma of solid tumors, including prostate cancer, has
               been shown to be immunosuppressive and associated with induced resistance to tumor-targeted
               immunotherapies; however, the mechanisms remain complex [20,21] . Recent studies have shown that either
               reprogramming subsets of stromal cells or immunotherapies targeting stromal antigens can disrupt the pro-
               tumorigenic  microenvironment  niche  and  enhance  endogenous  or  vaccine-induced  antitumor
               immunity [20-24] . In this review, we will discuss the current knowledge about stromal evolution in prostate
               cancer tumorigenesis and its known regulation of the tissue-immune landscape. Understanding this will
               help in developing effective therapeutic strategies that can be leveraged to co-target peri-tumoral reactive
               stroma to reprogram the immune suppressive tumor microenvironment (TME) and render it permissive to
               antitumor immunotherapies.


               PROSTATE GLAND AT HOMEOSTASIS
               An integrative network involving various cellular and acellular components regulates the structure,
               function, and homeostasis of the prostate gland. The acinar epithelial cells constitute the functional
   68   69   70   71   72   73   74   75   76   77   78